In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 (coronavirus)

It is with great regret that I inform you that Heart Failure 2020 & the World Congress on Acute Heart Failure, scheduled for 23–26 May in Barcelona, is officially cancelled. 

The leadership of the ESC and the Heart Failure Association (HFA) have been closely following the current health crisis. The spread of COVID-19 around the world and the necessity for healthcare professionals to deal with the epidemic in their hospitals has impacted the availability of both faculty and delegates. Indeed, many have already cancelled their plans to attend – and that number will only grow. In addition, the Spanish authorities have declared a state of emergency while the Catalan government has imposed a total lockdown and severe travel bans.

As a result of these factors and our responsibility to protect the health of our faculty, delegates and staff, the HFA leadership has decided that cancelling Heart Failure 2020 is the only responsible course of action.

Should you have any queries, please refer to the FAQ.

On behalf of the HFA board, we convey our heartfelt wishes to you, your families and your patients in these difficult times.  

Petar Seferović

ESC Heart Failure Association

President 2018–2020


Exhibition and Industry

Heart Failure 2020, 23-26 May, Barcelona

Keep some time in your agenda to visit the exhibition and include industry sponsored sessions in your agenda for the most recent information on the latest products, therapies and research from our industry partners.


Exhibition 1 HF 2019.jpgThe exhibition provides delegates with the opportunity to exchange with key industry experts on critical areas of development and research in cardiovascular products and therapies. 

Company & Product Description will be available in the Mobile App.



Satellite Symposia

ISS HF 2019.jpg

These sessions offer pertinent data on the latest scientific information and developments from industry.

See details on the Programme Planner or the Mobile App.

Experts on the Spot

EOTS HF 2019.jpgThese sessions provide delegates attending or interested in satellite symposia with a further opportunity to question and exchange with topic experts in a concise and interactive format on the session content.

More details on the programmes on the Scientific Programme & Planner and on the Mobile App.

Practical Tutorials

heart-failure-2015-cprworkshops2.jpgPractical Tutorials offer delegates a unique opportunity for hands-on and/or one-on-one learning from clinical and/or technical experts on specific areas of expertise, allowing them to address issues essential to their daily practice.

More details on the programmes on the Scientific Programme & Planner and on the Mobile App.


Industry @ Heart Failure 

The ESC gratefully acknowledges the following companies and organisations who contributed to the success of Heart Failure 2019:

  • Abbott
  • Alnylam Pharmaceuticals
  • AstraZeneca
  • Bayer AG
  • Bioventrix Inc.
  • Boehringer Ingelheim & Eli Lilly Alliance
  • Boston Scientific International SA
  • Charité
  • CHF Solutions
  • Critical Diagnostics
  • Fresenius Medical Care
  • Impluse Dynamics Germany GmbH
  • Medscape Education
  • Medtronic
  • MyoKardia
  • Novartis Pharmaceuticals AG
  • Orion Corporation Orion Pharma
  • Pfizer Inc
  • Physicians Academy for Cardiovascular Education
  • Quidel Germany GmbH
  • Radcliffe Cardiology
  • Reprieve Cardiovascular, Inc.
  • Roche Diagnostics International Ltd
  • SQ Innovation
  • Thermo Fisher Scientific
  • Vifor (International) AG
  • WeHealth by Servier
  • Wisepress LTD

 (Valid as of 28/08/2019)